Faculté de Médecine, Université de Nancy, Vandoeuvre-lès-Nancy, France.
Intensive Care Med. 2011 May;37(5):861-9. doi: 10.1007/s00134-011-2169-5. Epub 2011 Mar 3.
To study the activation and expression of vascular (aorta and small mesenteric arteries) potassium channels during septic shock with or without modulation of the NO pathway.
Septic shock was induced in rats by peritonitis. Selective inhibitors of vascular K(ATP) (PNU-37883A) or BK(Ca) [iberiotoxin (IbTX)] channels were used to demonstrate their involvement in vascular hyporeactivity. Vascular response to phenylephrine was measured on aorta and small mesenteric arteries mounted on a wire myograph. Vascular expression of potassium channels was studied by PCR and Western blot, in the presence or absence of 1400W, an inducible NO synthase (iNOS) inhibitor. Aortic activation of the transcriptional factor nuclear factor-kappaB (NF-κB) was assessed by electrophoretic mobility shift assay.
Arterial pressure as well as in vivo and ex vivo vascular reactivity were reduced by sepsis and improved by PNU-37883A but not by IbTX. Sepsis was associated with an up-regulation of mRNA and protein expression of vascular K(ATP) channels, while expression of vascular BK(Ca) channels remained unchanged. Selective iNOS inhibition blunted the sepsis-induced increase in aortic NO, decreased NF-κB activation, and down-regulated vascular K(ATP) channel expression.
Vascular K(ATP) but not BK(Ca) channels are activated, over-expressed, and partially regulated by NO via NF-κB activation during septic shock. Their selective inhibition restores arterial pressure and vascular reactivity and decreases lactate concentration. The present data suggest that selective vascular K(ATP) channel inhibitors offer potential therapeutic perspectives for septic shock.
研究脓毒症休克时血管(主动脉和小肠系膜动脉)钾通道的激活和表达,以及是否对 NO 途径进行调节。
通过腹膜炎诱导大鼠发生脓毒症休克。使用血管 K(ATP)(PNU-37883A)或 BK(Ca) [iberiotoxin (IbTX)] 通道的选择性抑制剂来证明它们在血管低反应性中的作用。使用线描记器测量主动脉和小肠系膜动脉上的酚妥拉明血管反应。通过 PCR 和 Western blot 研究钾通道的血管表达,同时存在或不存在诱导型一氧化氮合酶(iNOS)抑制剂 1400W。通过电泳迁移率变动分析评估转录因子核因子-κB(NF-κB)在主动脉中的激活。
动脉压以及体内和体外血管反应性在脓毒症时降低,PNU-37883A 可改善,而 IbTX 则不可改善。脓毒症与血管 K(ATP)通道的 mRNA 和蛋白表达上调有关,而血管 BK(Ca)通道的表达保持不变。选择性 iNOS 抑制减弱了脓毒症引起的主动脉 NO 增加,降低了 NF-κB 激活,并下调了血管 K(ATP)通道的表达。
在脓毒症休克期间,血管 K(ATP)但不是 BK(Ca)通道通过 NF-κB 激活被激活、过度表达,并部分受 NO 调节。它们的选择性抑制恢复了动脉压和血管反应性,并降低了乳酸浓度。这些数据表明,选择性血管 K(ATP)通道抑制剂为脓毒症休克提供了潜在的治疗前景。